May 28, 2009 -- WuXi PharmaTech Inc. (NYSE: WX) reported Q1 revenues were 69% higher than year-earlier numbers at $57.1 million. However, this year’s revenue includes an $11 million contribution from the AppTec acquisition, which was closed on January 31, 2008. Without AppTec, WuXi’s revenues grew by 36%. Net income jumped 132% to $13.9 million, which works out to an earnings per ADS figure of 19 cents. WuXi reiterated its guidance of 2008 revenues in a $280 million-$300 million range. More details...
